Tiziana Life Sciences Ltd., a biotechnology company pioneering breakthrough immunomodulation therapies, has entered a ...
Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.
The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...
KEY POINTS Chronic rhinosinusitis refers to symptomatic inflammation of the nose and paranasal sinuses that has been present ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback